Deadly Bariatrics, 1960s and '70s

Resecting a majority of the small intestine—a popular weight-loss surgery half a century ago—led to severe malnutrition and eventual death.

Written byJef Akst
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

CUT-AND-PASTE GI TRACT: The intestine is divided into three segments: the duodenum, the jejunum, and the ileum. Surgeons performing jejunoileal bypass surgery would sever the small intestine in the jejunal region, about 35 cm below its attachment to the ligament of Treitz. The cut end was then sewn into an area of the ileal segment, about 10 cm from its natural attachment to the large intestine, or colon. As a result, about 90 percent of the small bowel was bypassed, greatly limiting micronutrient absorption. The remaining section of small intestine itself rarely caused any problems, but patients who underwent the procedure suffered severe malnutrition, often leading to organ failure and death. CLEVELAND CLINICIn 2009, Dushyant Singh, a gastroenterologist at Overland Park Regional Medical Center in Shawnee, Kansas, met a 64-year-old man with advanced liver disease, as well as a long history of kidney stones, progressive kidney disease, arthritis, diarrhea, fatigue, joint pain, slurred speech, and other concerning symptoms. His case was peculiar, and doctors could not pinpoint the cause of his deteriorating condition. The patient eventually mentioned having had “weight-loss surgery” in the mid-1970s, but upper endoscopy showed no sign of a modern gastric-bypass procedure. Singh wondered if the patient had undergone jejunoileal bypass, a once wildly popular weight-loss surgery that was later discovered to cause a slew of health problems, some fatal (World J Gastroenterol, 15:2277-79, 2009).

Doctors first began offering jejunoileal bypass, one of the earliest bariatric surgeries, in the late 1960s, after surgeons noticed that patients who had lost a portion of their small intestine would lose weight, even as they ate more. The procedure involved bypassing about 90 percent of the small intestine to short-circuit nutrient absorption. And it worked. Patients immediately started shedding pounds. More than 100,000 overweight people chose to undergo the surgery. “Every decade has a new fashion,” says Singh. “[Jejunoileal bypass] was the fashion statement in the early ’70s. Everybody was getting this.”

But in addition to absorbing fewer calories from the food they ate, jejunoileal bypass patients were also absorbing fewer micronutrients. Soon, they began having trouble seeing at night because they became deficient ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies